ArticleJournal of cosmetic dermatology2025
Consensus Statements on Managing Aesthetic Needs in Prescription Medication-Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Aesthetic Considerations for Preventing and Managing GLP-1 Receptor Agonist-Related Facial Aging.The Journal of clinical and aesthetic dermatology · 2026Article
- A Multicenter, Open-Label Study of Combined Poly-L-Lactic Acid and Hyaluronic Midface Filler Regimen Enhances Facial Harmony and Skin Quality in GLP-1 Medication Users.Aesthetic surgery journal · 2026Article
- Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-ultrasound Procedure for Subjects Undergoing Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy.Dermatology and therapy · 2026Article
- Enhancing Fat Graft Survival with Poly-L-Lactic Acid: An Experimental Study in Wistar Rats.Aesthetic plastic surgery · 2026Article
- Nonsurgical Aesthetic Treatment of the Face and Neck in GLP-1 Receptor Agonist Weight Loss Patients: Experience-Based Considerations.Aesthetic surgery journal. Open forum · 2026Article
- Managing Aesthetic Needs in Prescription Medication-Driven Rapid Weight Loss Patients: Results of an International Consensus. The Clinician Perspective.Journal of cosmetic dermatology · 2026Article
- Rising Public Interest in Weight Loss Medications and Growing Awareness of Their Aesthetic Sequelae: An Infodemiologic Google Trends Analysis and Clinical Diagnostic Patterning.Journal of cosmetic dermatology · 2026Article
- Aesthetic Use of Poly-L-Lactic Acid and Hyaluronic Acid Fillers in Medication-Driven Weight Loss Due to GLP-1 Receptor Agonists: Real-World Case Series from Latin America.Clinical, cosmetic and investigational dermatology · 2026Article
- Semaglutide in the Real World: Attitudes of the Population.Pharmacy (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo handle the increasing influx of prescription medication-driven weight loss (mdWL) patients in aesthetic practices, clinicians must be aligned on identifying discerning factors and strategies for managing this unique patient population.
objectives(1) Define the mdWL patient; (2) describe the mdWL patient's aesthetic expectations; (3) determine the most relevant methods of assessing mdWL patients in clinical practice; (4) determine the effects of mdWL on specific facial tissue layers; (5) identify important treatment considerations for the mdWL patient; and (6) identify the temporal sequencing of non-surgical options in the mdWL patient.
methodsPreparatory research included patient interviews, market research, and a systematic literature review. Following this, an international, multidisciplinary three-round Delphi study was conducted to collect information on practice setting, physician and patient demographics, and previous experience, and for panelists to vote on consensus statements regarding managing mdWL patients in aesthetics.
resultsmdWL is best defined by the percent of BMI lost within ≤ 6 months. Three-dimensional volumetric analysis is an effective quantitative assessment, while photo-numeric scales and patient-reported outcome measures are relevant qualitative measures. Tissue layers most affected by mdWL include the skin and superficial and deep fat pads. A major concern for aesthetic mdWL patients seeking aesthetic treatments is the fear of appearing to have gained weight following treatments, while for physicians it is ensuring their mdWL patients look healthy and natural. The key selection and critical timing of aesthetic treatments throughout the mdWL journey are described.
conclusionsThe first global consensus-based guidelines for understanding and managing the aesthetic needs of mdWL patients are presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.